Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Disclaimer: Calculator results and default inputs are ...

AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) in combination with pertuzumab has been approved in the US for the 1st-line treatment of adult patients with unresectable or ...

Most stock quote data provided by BATS. US market indices are shown in real time, except for the S&P 500 which is refreshed every two minutes. All times are ET ...

Reverse Stock Split Aligns Share Structure with New Revenue-Generating Business Model; Final Step in Corporate Transformation SCOTTSDALE, AZ / ACCESS Newswire / December 9, 2025 / Bonk, Inc.